HCMI has released 137 patient-derived next-generation cancer models from 17 tumor types!
HCMI: Human Cancer Models Initiative
The Human Cancer Models Initiative (HCMI) is an international consortium that is generating novel, next-generation, tumor-derived culture models annotated with clinical, biospecimen, and molecular characterization data. HCMI-developed models and case-associated data are available as a community resource. NCI is contributing to the initiative by supporting four Cancer Model Development Centers (CMDCs).